Claims
- 1. A pyridinecarboximidamide derivative represented by the following formula (I) or an acid adduct salt thereof: ##STR97## wherein X is a hydrogen atom or a chlorine atom,
- R is --R.sup.1 or ##STR98## wherein R.sup.1 is ##STR99## wherein R.sup.4 is an alkyl group with 1-3 carbon atoms or an alkoxyl group with 1-3 carbon atoms and b is an integer of 0-1,
- R.sup.2 is a hydrogen atom and a is an integer of 1-2, ##STR100## wherein R.sup.5 is one or more members selected from the group consisting of an alkyl group with 1-3 carbon atoms, an alkoxyl group with 1-3 carbon atoms, a phenylalkoxyl group with 1-3 carbon atoms in the alkoxyl moiety, a nitro group, an amino group, an alkylamino group with 1-3 carbon atoms, a phenylalkylamino group with 1-3 carbon atoms in the alkyl moiety, an alkylthio group with 1-3 carbon atoms, a perfluoroalkyl group with 1-3 carbon atoms or a halogen atom, c is an integer of 0-2 and when c is 2, two R.sup.5 's may be the same or different members in the aforementioned group.
- 2. A pyridinecarboximidamide derivative or an acid adduct salt thereof according to claim 1, wherein X in formula (I) is a hydrogen atom.
- 3. A pyridinecarboximidamide derivative or an acid adduct salt thereof according to claim 1, wherein X in formula (I) is a chlorine atom and R in the formula is ##STR101##
- 4. A pyridinecarboximidamide derivative or an acid adduct salt thereof according to claim 2, wherein in R.sup.4, the alkyl group is methyl and the alkoxy group is methoxy;
- in R.sup.5, the alkyl group is methyl, the alkoxyl group is methoxy, the alkylamino group is dimethylamino, the phenylalkoxyl group is benzyloxyl, the phenylalkylamino group is benzylamino, the alkylthio group is methylthio, the perfluoroalkyl group is perfluoromethyl and a halogen atom is chlorine.
- 5. A pyridinecarboximidamide derivative or an acid adduct salt thereof according to claim 1, which is selected from the group consisting of the following compounds or an acid adduct salt thereof:
- N-cyano-N'-phenyl-2-pyridinecarboximidamide;
- N-cyano-N'-(4-methoxyphenyl)-2-pyridinecarboximidamide;
- N-cyano-N'-(4-methylbenzyl-2-pyridinecarboximidamide;
- N-cyano-N'-(4-chlorobenzyl)-2-pyridinecarboximidamide;
- N-cyano-N'-[4-(trifluoromethyl)benzyl)-2-pyridinecarboximidamide;
- N-cyano-N'-[2-(4-methylphenyl)ethyl]-2-pyridinecarboximidamide;
- N-cyano-N'-[2-(4-chlorophenyl)ethyl]-2-pyridinecarboximidamide;
- N-cyano-N'-(2-thienylmethyl)-2-pyridinecarboximidamide;
- N-cyano-N'-(4-methylphenyl)-3-pyridinecarboximidamide;
- N-cyano-N'-benzyl -3-pyridinecarboximidamide;
- N-cyano-N'-(4-methylbenzyl)-3-pyridinecarboximidamide;
- N-cyano-N'-(4-methoxybenzyl)-3-pyridinecarboximidamide;
- N-cyano-N'-(4-dimethylaminobenzyl)-3-pyridinecarboximidamide;
- N-cyano-N'-[4-(trifluoromethyl)benzyl[-3-pyridinecarboximidamide;
- N-cyano-N'-(4-chlorobenzyl)-3-pyridinecarboximidamide;
- N-cyano-N'-(4-nitrobenzyl)-3-pyridinecarboximidamide;
- N-cyano-N'-(3,4-dichlorobenzyl)-3-pyridinecarboximidamide;
- N-cyano-N'-[3,5-bis(trifluoromethyl)benzyl]-3-pyridinecarboximidamide;
- N-cyano-N'-(3-benzyloxybenzyl)-3-pyridinecarboximidamide;
- N-cyano-N'-(2-phenylethyl)-3-pyridinecarboximidamide;
- N-cyano-N'-[2-(2-methoxyphenyl)ethyl]-3-pyridinecarboximidamide;
- N-cyano-N'-[2-(2-chlorophenyl)ethyl]-3-pyridinecarboximidamide;
- N-cyano-N'-[2-(4-chlorophenyl)ethyl]-3-pyridinecarboximidamide;
- N-cyano-N'-[2-(4-benzylaminophenyl)ethyl]-3-pyridinecarboximidamide;
- N-cyano-N'-[2-(3,4-dibenzyloxyphenyl)ethyl]-3-pyridinecarboximidamide;
- N-cyano-N'-phenyl-4-pyridinecarboximidamide;
- N-cyano-N'-(3,4-dichlorobenzyl)-4-pyridinecarboximidamide;
- N-cyano-N'-(4-methylthiobenzyl)-4-pyridinecarboximidamide;
- N-cyano-N'-(3-benzyloxybenzyl)-4-pyridinecarboximidamide;
- N-cyano-N'-[2-(4-chlorophenyl)ethyl]-4-pyridinecarboximidamide;
- N-cyano-N'-[2-(2-methoxyphenyl)ethyl]-4-pyridinecarboximidamide;
- N-cyano-N'-(2-phenylthioethyl)-4-pyridinecarboximidamide; and
- N-cyano-N'-(2-phenylethyl)-3-(6-chloropyridine)carboximidamide.
- 6. A pyridinecarboximidamide derivative or an acid adduct salt thereof according to claim 1, which is selected from the group consisting of the following compounds or an acid adduct salt thereof:
- N-cyano-N'-benzyl-3-pyridinecarboximidamide;
- N-cyano-N'-(2-phenylethyl)-3-pyridinecarboximidamide; and
- N-cyano-N'-[2-(2-chlorophenyl)ethyl]-3-pyridinecarboximidamide.
- 7. A hypotensor comprising as an effective ingredient a pyridinecarboximidamide derivative or an acid adduct salt thereof according to claim 1 and a carrier or diluent, wherein the pyridinecarboximidamide derivative is selected from the group consisting of the following compounds:
- N-cyano-N'-benzyl-3-pyridinecarboximidamide;
- N-cyano-N'-(2-phenylethyl)-3-pyridinecarboximidamide; and
- N-cyano-N'-[2-(2-chlorophenyl)ethyl]-3-pyridinecarboximidamide.
- 8. A hypotensor comprising as an effective ingredient a pyridinecarboximidamide derivative or an acid adduct salt thereof according to claim 1 and a carrier or diluent, wherein the pyridinecarboximidamide derivative is the following compound or an acid adduct salt thereof:
- N-cyano-N'-[2-(2-chlorophenyl)ethyl]-3-pyridinecarboximidamide.
- 9. A method for decrease in blood pressure, characterized in that the effective amount of a pyridinecarboximidamide derivative or an acid adduct salt thereof according to claim 1 and a carrier or diluent, wherein the pyridinecarboximidamide derivative is selected from the group consisting of the following compound are administered to a patient who needs decrease in blood pressure or an acid adduct salt thereof:
- N-cyano-N'-benzyl-3-pyridinecarboximidamide;
- N-cyano-N'-(2-phenylethyl)-3-pyridinecarboximidamide; and
- N-cyano-N'-[2-(2-chlorophenyl)ethyl]-3-pyridinecarboximidamide.
- 10. A method for decrease in blood pressure, characterized in that the effective amount of a pyridinecarboximidamide derivative or an acid adduct salt thereof according to claim 1 and a carrier or diluent wherein the pyridinecarboximidamide derivative is the following compound or an acid adduct salt thereof are administered to a patient who needs decrease in blood pressure:
- N-cyano-N'-[2-(2-chlorophenyl)ethyl]-3-pyridinecarboximidamide.
Parent Case Info
This is a divisional of copending application(s) Ser. No. 07/455,973 filed on Dec. 22, 1989 now U.S. Pat. No. 5,166,347.
Non-Patent Literature Citations (2)
Entry |
Kinney et al. Journal of Medicinal Chemistry, vol. 33, pp. 327-336, 1990. |
Izawa et al., Chemical Abstracts, vol. 114, No. 23, Abstract 228,747g, p. 822, Jun. 10, 1991. |
Divisions (1)
|
Number |
Date |
Country |
Parent |
455973 |
Dec 1989 |
|